Flagship Private Wealth’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$588K Hold
3,091
0.21% 68
2026
Q1
$522K Buy
3,091
+7
+0.2% +$1.2K 0.21% 65
2025
Q4
$521K Buy
3,084
+60
+2% +$9.74K 0.2% 67
2025
Q3
$437K Sell
3,024
-127
-4% -$17.3K 0.18% 72
2025
Q2
$399K Sell
3,151
-235
-7% -$28.8K 0.17% 71
2025
Q1
$433K Buy
3,386
+3
+0.1% +$407 0.21% 64
2024
Q4
$447K Buy
3,383
+2
+0.1% +$281 0.22% 64
2024
Q3
$492K Buy
3,381
+20
+0.6% +$2.89K 0.25% 63
2024
Q2
$461K Sell
3,361
-672
-17% -$89.7K 0.27% 58
2024
Q1
$553K Buy
4,033
+676
+20% +$92.3K 0.36% 53
2023
Q4
$456K Buy
3,357
+7
+0.2% +$854 0.35% 50
2023
Q3
$410K Hold
3,350
0.36% 49
2023
Q2
$425K Hold
3,350
0.35% 51
2023
Q1
$433K Sell
3,350
-39
-1% -$5.11K 0.39% 47
2022
Q4
$445K Buy
3,389
+204
+6% +$26.4K 0.42% 44
2022
Q3
$373K Buy
3,185
+61
+2% +$7.58K 0.38% 50
2022
Q2
$367K Buy
3,124
+1
+0% +$119 0.36% 52
2022
Q1
$407K Sell
3,123
-45
-1% -$5.86K 0.33% 51
2021
Q4
$484K Sell
3,168
-35
-1% -$5.42K 0.35% 48
2021
Q3
$518K Buy
3,203
+3
+0.1% +$505 0.41% 48
2021
Q2
$517K Buy
3,200
+234
+8% +$36K 0.39% 45
2021
Q1
$451K Buy
2,966
+2,260
+320% +$359K 0.38% 47
2020
Q4
$113K Buy
+706
New +$101K 0.1% 77

Other funds holding IBB

Flagship Private Wealth's IBB Position: Q2 2026 in Review

Flagship Private Wealth held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 3,091 shares worth $588K. The position accounts for 0.21% of the portfolio, ranked #68.

Flagship Private Wealth first reported a position in IBB in Q4 2020 and has held it in 23 quarters since. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Flagship Private Wealth held 3,091 shares of iShares Biotechnology ETF worth $588K as of Q2 2026.
  • Flagship Private Wealth left its iShares Biotechnology ETF share count unchanged in Q2 2026.
  • iShares Biotechnology ETF made up 0.21% of Flagship Private Wealth's portfolio in Q2 2026, its #68 holding.
  • Flagship Private Wealth first reported a position in iShares Biotechnology ETF in Q4 2020 and has held it in 23 quarters since.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Flagship Private Wealth's 13F filing for Q2 2026, filed 4 Aug 2026.